Targeting the UPS as Therapy in Multiple Myeloma

DSpace/Manakin Repository

Targeting the UPS as Therapy in Multiple Myeloma

Citable link to this page

. . . . . .

Title: Targeting the UPS as Therapy in Multiple Myeloma
Author: Bianchi, Giada; Chauhan, Dharminder; Anderson, Kenneth Carl

Note: Order does not necessarily reflect citation order of authors.

Citation: Chauhan, Dharminder, Giada Bianchi, and Kenneth C. Anderson. 2008. Targeting the UPS as therapy in multiple myeloma. BMC Biochemistry 9(Suppl 1): S1.
Full Text & Related Files:
Abstract: The coordinated regulation of cellular protein synthesis and degradation is essential for normal cellular functioning. The ubiquitin proteasome system mediates the intracellular protein degradation that is required for normal cellular homeostasis. The 26S proteasome is a multi-enzyme protease that degrades redundant proteins; conversely, inhibition of proteasomal degradation results in intracellular aggregation of unwanted proteins and cell death. This observation led to the development of proteasome inhibitors as therapeutics for use in cancer. The clinical applicability of targeting proteasomes is exemplified by the recent FDA approval of the first proteasome inhibitor, bortezomib, for the treatment of relapsed/refractory multiple myeloma. Although bortezomib represents a major advance in the treatment of this disease, it can be associated with toxicity and the development of drug resistance. Importantly, extensive preclinical studies suggest that combination therapies can both circumvent drug resistance and reduce toxicity. In addition, promising novel proteasome inhibitors, which are distinct from bortezomib, and exhibit equipotent anti-multiple myeloma activities, are undergoing clinical evaluation in order to improve patient outcome in multiple myeloma. Republished from Current BioData's Targeted Proteins database (TPdb; http://www.targetedproteinsdb.com).
Published Version: doi:10.1186/1471-2091-9-S1-S1
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582802/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:8231689

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters